Novo is a leading global healthcare company, founded in 1923 and headquartered in Denmark. 

We believe lasting health starts now. 

We pioneer scientific breakthroughs, expand access to our medicines, and work to in strategic partnerships to create meaningful change for millions of people living with chronic diseases. 

  • Therapy areas: Diabetes, ​Obesity, Rare Disease, Cardiovascular & Emerging Therapy Areas​
  • Globally serving more than 46.5 million people living with serious chronic diseases​

    Learn more about our therapy areas

 

  • Number of employees: 67,000​ 
  • Number of employees in DK: 33.700
  • Number of employees in US: 11.200 
  • Affiliates in 80 countries​ 

 

  • Strategic production sites in Belgium, Brazil, China, Denmark, France, Italy and the US​

Our medicines

 

  • Corporate income tax in Denmark in Q2 2026: 7 bn DKK